The product that will be distributed under the agreement will be Baymix® Grobig® BS, a feed additive based on AgraQuest’s patented strain of Bacillus subtilis and co-branded with AgraQuest’s trademark Sympatic™. Baymix Grobig BS has already received registration in India, Korea and Thailand and is already marketed by Bayer Animal Health in these countries. It will be launched in other key markets throughout Asia and Latin America, with registrations currently in process in eight countries.
“Bayer is looking forward to a long-term relationship with AgraQuest which will contribute to further foster our target to complete our customers’ needs,” says Alexander Jahn, Head of Region Asia within Bayer HealthCare Animal Health. “We already started to partner successfully in selected countries like India for example, which is one of the fastest growing poultry markets in Asia. With our excellent distribution footprint across most of the growing markets, we will contribute to a continuous success of Baymix Grobig, especially in those markets, where the importance of poultry is increasing.”
Baymix Grobig BS is a product designed to be complementary to existing poultry health regimes, brings balance to microflora of the intestinal tract of poultry. The genetically distinct QST 713 strain enhances digestion and has been shown to protect birds from profit robbing diseases such as necrotic enteritis.
“By teaming with Bayer in these key poultry markets, we can deliver to producers a product that allows treated poultry to reach their full genetic potential and maximise their return on investment,” said Joe Schmidt, Vice President at AgraQuest. “We look forward to working with the Bayer country teams on this exciting offering.”
Related websites:
AgraQuest
The Bayer Group
